Project Highlights

• We are able to predict functional mammalian promoter sequences
• We have created a functional biochemical synthesis method for the generation of promoters libraries
• We have developed novel standards for measurement of promoters in mammalian cells
• 4 RFCs, well characterized parts

We are able to predict functional mammalian promoter sequences

We created HEARTBEAT, a model portfolio based upon genome-wide bioinformatic analysis and fuzzy logic. We used these tools to predict promoter sequences. Then, we synthesized such sequences. We found that promoters most closely matching the model predictions work, whereas others don't. Read more about these results on the "HEARTBEAT database" page. We also present a GUI which enables you to design the promoter of your needs.

HEARTBEAT describes the spatial distribution of Transcription Factor Binding Sites along a mammalian promoter. The diagram on the top shows this distribution for SREBP. HEARTBEAT also describes Transcription Factors co-occurring with a given TF, which, for SREBP, is Sp1. We placed SREBP and Sp1 Binding sites according to the predicted distribution and found only promoters which resemble the distribution closest to be induced by SREBP (see small diagram). Other promoter sequences are not functional (not shown).

We have created a functional biochemical synthesis method for the generation of promoters libraries

We developed RA-PCR, a biochemical method for the generation of randomized promoter libraries. We created a library of constitutive promoters, a NF-κB responsive promoter which underwent extensive characterization and some other regulated promoters.

The method of RA-PCR. By combining Oligos with transcription factor binding sites (TFBS) and mutually annealing sequences in a single , we generate randomized repeats of such TFBSs at random spacing, making it likely to produce functional promoters at different strength.

A library of constitutive promoters of different strength created by RA-PCR.

NF-κB regulated promoter created by RA-PCR which becomes active (green fluorescence) if NF-κB localizes to the nucleus (red fluorescence within the nucleus)

We have developed novel standards for measurement of promoters in mammalian cells

Applying both qRT-PCR and flow cytometry, we developed two new relative units in analogy to bacterial RPU for use in mammalians: Relative Expression Units and Relative Mammalian Promoter Units. We apply these units to the characterization of our promoters, as well as an existing promoter from the registry. Read more about our Measurement sub-project.

Strength of the CMV promoter in different cell lines in REU. Relative Expression Units (REU) was determined by Flow cytometry; in HeLa and MCF-7 cells, this measurement was confirmed by an independent technique (Image analysis). 3 experiments on different days, three replicates for each measurement.

Real-time RT-PCR data of cmv promoter. One group of HeLa cells were transfected with plasmid containing CMV promoter coupled to GFP. Another group was transfected with JeT promoter coupled to GFP served as reference. Total RNA generated by CMV was divided by total RNA generated by JET to obtain RMPU .

4 RFCs, well characterized parts

We stick with the standards required by synthetic biology and submit all the methods and units we developed as RFCs (Request for Comments). By introducing new standards for synthetic biology in mammalian cells, we hope to set a process in motion that will allow the number of mammalian parts in the registry to skyrocket within the next years:

• RCF 41: Units for Promoter Measurement in Mammalian Cells
• RFC 42: RA-PCR, a method for the generation of randomized promoter libraries
• RFC 43: Design of specific mammalian promoters by in silico prediction
• RFC 45: Cloning Standard for Mammalian BioBrick Parts and Devices

We also submit more than 10 well-characterized parts to the registry (see Parts Characterization). Also, we submit several other parts, for which we offer at least a rough characterization (Find our full parts list here)